Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Kazuhisa, Tanaka"'
Publikováno v:
Thoracic Cancer, Vol 14, Iss 22, Pp 2229-2232 (2023)
Abstract Bronchopleural fistulas are rare complications of bevacizumab treatment. Herein, we report a case of bronchopleural fistula after bevacizumab therapy. The patient was a 65‐year‐old man with lung cancer who underwent a right lower lobecto
Externí odkaz:
https://doaj.org/article/311f07a9736b4b969e905f864ccb3064
Autor:
Taisuke Kaiho, Hidemi Suzuki, Atsushi Hata, Hiroki Matsumoto, Kazuhisa Tanaka, Yuichi Sakairi, Shinichiro Motohashi, Ichiro Yoshino
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Immune checkpoint molecules such as programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) have revolutionized the field of lung cancer treatment. As part of our study, we examined the role of these proteins in acute rejection in a mouse mod
Externí odkaz:
https://doaj.org/article/eced30ae2d39482abc151933646f56c1
Autor:
Hideki Terai, MD, Kenzo Soejima, MD, Asanao Shimokawa, PhD, Hidehito Horinouchi, MD, Junichi Shimizu, MD, Tetsunari Hase, MD, Ryota Kanemaru, MD, Kana Watanabe, MD, Kiichiro Ninomiya, MD, Naoko Aragane, MD, Noriko Yanagitani, MD, Yoshihiko Sakata, MD, Masahiro Seike, MD, Daichi Fujimoto, MD, Masashi Kasajima, MD, Akihito Kubo, MD, Sojiro Kusumoto, MD, Yoshitaka Oyamada, MD, Keiichi Fujiwara, MD, Masahide Mori, MD, Midori Hashimoto, MD, Masato Shingyoji, MD, Masahiro Kodani, MD, Jin Sakamoto, MD, Toshihiko Agatsuma, MD, Kosuke Kashiwabara, MD, Minehiko Inomata, MD, Motoko Tachihara, MD, Kazuhisa Tanaka, MD, Kenji Hayashihara, MD, Nobuyuki Koyama, MD, Kaoru Matsui, MD, Koichi Minato, MD, Daisuke Jingu, MD, Hiroyuki Sakashita, MD, Satoshi Hara, MD, Tomoyuki Naito, MD, Asuka Okada, MD, Masayuki Tanahashi, MD, Yuki Sato, MD, Koichiro Asano, MD, Takayuki Takeda, MD, Kensuke Nakazawa, MD, Toshiyuki Harada, MD, Kazuhiko Shibata, MD, Tatsuo Kato, MD, Etsuo Miyaoka, PhD, Ichiro Yoshino, MD, Akihiko Gemma, MD, Tetsuya Mitsudomi, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 11, Pp 100404- (2022)
Introduction: Pembrolizumab is a programmed death-ligand 1 inhibitor that was initially indicated for monotherapy in patients with advanced lung cancer. The Japanese Lung Cancer Society conducted an observational study on pembrolizumab using confirma
Externí odkaz:
https://doaj.org/article/67a827674fcd4c4087dafceff77375be
Autor:
Hiroki Matsumoto, Hidemi Suzuki, Takahiro Yamanaka, Taisuke Kaiho, Atsushi Hata, Terunaga Inage, Takamasa Ito, Toshiko Kamata, Kazuhisa Tanaka, Yuichi Sakairi, Shinichiro Motohashi, Ichiro Yoshino
Publikováno v:
Life, Vol 13, Iss 10, p 2042 (2023)
Antibody-mediated rejection (AMR) is a risk factor for chronic lung allograft dysfunction, which impedes long-term survival after lung transplantation. There are no reports evaluating the efficacy of the single use of anti-CD20 antibodies (aCD20s) in
Externí odkaz:
https://doaj.org/article/aa5479d170a44e369c4a00e9097f255c
Autor:
Yuki Onozato, Takahiro Nakajima, Hajime Yokota, Jyunichi Morimoto, Akira Nishiyama, Takahide Toyoda, Terunaga Inage, Kazuhisa Tanaka, Yuichi Sakairi, Hidemi Suzuki, Takashi Uno, Ichiro Yoshino
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Tumor spread through air spaces (STAS) in non-small-cell lung cancer (NSCLC) is known to influence a poor patient outcome, even in patients presenting with early-stage disease. However, the pre-operative diagnosis of STAS remains challenging
Externí odkaz:
https://doaj.org/article/a3a4c781ec0f4f2e88b0e892e423e60d
Autor:
Hajime Kasai, Kiyoshi Shikino, Go Saito, Tomoko Tsukamoto, Yukiko Takahashi, Ayaka Kuriyama, Kazuhisa Tanaka, Misaki Onodera, Hidetaka Yokoh, Koichiro Tatusmi, Ichiro Yoshino, Masatomi Ikusaka, Seiichiro Sakao, Shoichi Ito
Publikováno v:
BMC Medical Education, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background The COVID-19 pandemic has created a need for educational materials and methods that can replace clinical clerkships (CCs) for online simulated clinical practice (online-sCP). This study evaluates the impact of using simulated elec
Externí odkaz:
https://doaj.org/article/052a36c0aa0b48ada08b2be3b3909ad4
Autor:
Hiroki Matsumoto, Hidemi Suzuki, Takahide Toyoda, Terunaga Inage, Kazuhisa Tanaka, Yuichi Sakairi, Fumihiro Ishibashi, Takahiro Nakajima, Ichiro Yoshino
Publikováno v:
Surgical Case Reports, Vol 7, Iss 1, Pp 1-4 (2021)
Abstract Background Knowledge of anatomical abnormalities and variations in pulmonary vessels and bronchi is critical for patients requiring a lung segmentectomy. To the best of our knowledge, this is the first case of a tumor existing in the lower l
Externí odkaz:
https://doaj.org/article/7748ddd73db74443a3f43ba50676a972
Autor:
Yukiko Matsui, Shigetoshi Yoshida, Takekazu Iwata, Kazuhisa Tanaka, Takayoshi Yamamoto, Kai Nishii, Toshihiko Iizasa
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-5 (2019)
Abstract Background Pulmonary carcinoma patients with low pulmonary function cannot be treated surgically because of the high risk of complications. Diaphragmatic eventration is a disease characterized by diaphragmatic paralysis and dyspnea. Here, we
Externí odkaz:
https://doaj.org/article/e5c96d17573e4422886c3b6dbe721135
Autor:
Kazuhisa Tanaka, Takekazu Iwata, Kai Nishii, Yukiko Matsui, Tsukasa Yonemoto, Hidetada Kawana, Makiko Itami, Shigetoshi Yoshida, Toshihiko Iizasa
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-4 (2019)
Abstract Background Primary pulmonary leiomyosarcoma is a rare malignant tumor. We herein report a case of primary pulmonary leiomyosarcoma that was completely resected by surgery after neoadjuvant chemotherapy. Case presentation A 60-year-old man pr
Externí odkaz:
https://doaj.org/article/4046307391bc4b34bde6eb43fa629516
Autor:
Takahide Toyoda, Hidemi Suzuki, Takahiro Yamanaka, Taisuke Kaiho, Takamasa Ito, Kazuhisa Tanaka, Yuichi Sakairi, Ichiro Yoshino
Publikováno v:
Journal of Thoracic Disease. 15:1640-1647